Distribution and risk factor analysis for Clostridium difficile-associated diarrhea among hospitalized children over

Chunna Zhao1, Shu Guo1, Xiaoyun Jia1

  • 1Department of Gastroenterology Beijing Children' s Hospital Faculty of Digestive Diseases Capital Medical University National Clinical Research Center f or Digestive Diseases Beijing 100045 China.

Pediatric Investigation
|August 28, 2020
PubMed

Insights

Hospitalization for 10 days or more before diarrhea onset is a key risk factor for Clostridium difficile-associated diarrhea (CDAD) in children with antibiotic-associated diarrhea (AAD). This finding is crucial for preventing severe infections in pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Antibiotic-associated diarrhea (AAD) is common in children, with Clostridium difficile-associated diarrhea (CDAD) being a severe form.
  • Risk factors for pediatric CDAD remain incompletely understood, necessitating further investigation.

Purpose of the Study:

  • To determine the prevalence of CDAD among hospitalized children experiencing AAD.
  • To identify significant risk factors associated with CDAD in this pediatric population.

Main Methods:

  • Polymerase chain reaction (PCR) was used to detect C. difficile pathogenic genes (tcdA, tcdB) in stool samples from 197 children with AAD.
  • Children positive for tcdA or tcdB were classified into the CDAD group; others formed the non-CDAD group.

Main Results:

  • The CDAD rate was 42.6% (84/197) among children with AAD.
  • Univariate analysis identified duration of antibiotic therapy, length of hospitalization before diarrhea, and gastrointestinal operations as significant risk factors.
  • Multivariate analysis confirmed hospitalization for ≥ 10 days prior to diarrhea as an independent risk factor.

Conclusions:

  • Prolonged hospitalization (≥ 10 days) before diarrhea onset is a significant independent risk factor for developing CDAD in pediatric patients with AAD.
  • These findings can inform preventative strategies in hospitalized children receiving antibiotics.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
337
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
172
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
148
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
698